Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H26FNO |
Molecular Weight | 387.4891 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=CC=C(C(=O)C2=CN(CCCCCF)C3=CC=CC=C23)C4=C1C=CC=C4
InChI
InChIKey=NSCXPXDWLZORPX-UHFFFAOYSA-N
InChI=1S/C26H26FNO/c1-2-19-14-15-23(21-11-5-4-10-20(19)21)26(29)24-18-28(17-9-3-8-16-27)25-13-7-6-12-22(24)25/h4-7,10-15,18H,2-3,8-9,16-17H2,1H3
Molecular Formula | C26H26FNO |
Molecular Weight | 387.4891 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/27429655
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27429655
EAM-2201 acts as a full agonist with of cannabinoid receptors, CB1 and CB2. This compound was first identified in Japan in 2012 as an ingredient in synthetic cannabis smoking blends and belongs to narcotic substances, that is why was banned in some countries.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27429655
Curator's Comment: in silico predictions
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P21554|||Q5UB37 Gene ID: 1268.0 Gene Symbol: CNR1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27429655 |
0.38 nM [Ki] | ||
Target ID: P34972 Gene ID: 1269.0 Gene Symbol: CNR2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27429655 |
0.371 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26641707
EAM-2201 is extensively metabolized by CYPs and its metabolites can be used as an indicator of EAM-2201 abuse. In vitro metabolism of EAM-2201 has been investigated with human liver microsomes and major cDNA-expressed cytochrome P450 (CYP) isozymes using liquid chromatography-high resolution mass spectrometry (LC-HRMS). Incubation of EAM-2201 with human liver microsomes in the presence of NADPH resulted in the formation of 37 metabolites. Multiple CYPs, including CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2J2, 3A4, and 3A5, were involved in the metabolism of EAM-2201.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 20:14:45 GMT 2023
by
admin
on
Fri Dec 15 20:14:45 GMT 2023
|
Record UNII |
OO52S1U9ET
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-EAM-2201
Created by
admin on Fri Dec 15 20:14:45 GMT 2023 , Edited by admin on Fri Dec 15 20:14:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
71308187
Created by
admin on Fri Dec 15 20:14:45 GMT 2023 , Edited by admin on Fri Dec 15 20:14:45 GMT 2023
|
PRIMARY | |||
|
OO52S1U9ET
Created by
admin on Fri Dec 15 20:14:45 GMT 2023 , Edited by admin on Fri Dec 15 20:14:45 GMT 2023
|
PRIMARY | |||
|
DTXSID50745434
Created by
admin on Fri Dec 15 20:14:45 GMT 2023 , Edited by admin on Fri Dec 15 20:14:45 GMT 2023
|
PRIMARY | |||
|
1364933-60-7
Created by
admin on Fri Dec 15 20:14:45 GMT 2023 , Edited by admin on Fri Dec 15 20:14:45 GMT 2023
|
PRIMARY | |||
|
EAM-2201
Created by
admin on Fri Dec 15 20:14:45 GMT 2023 , Edited by admin on Fri Dec 15 20:14:45 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|